Disorders of bone and bone mineral metabolism

Handbook of Clinical Neurology

Volumn 120, Issue , 2014, Pages 865-887

  Komoroski, Monica ^a   Azad, Nasrin ^b   Camacho, Pauline ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

Calcium; Magnesium; Osteoporosis; Paget's disease; Phosphorus; Vitamin D

Indexed keywords

CALCIUM; MAGNESIUM; PHOSPHORUS; VITAMIN D;

ARTICLE; BONE DENSITY; BONE DISEASE; HUMAN; METABOLISM; OSTEOPOROSIS; PAGET BONE DISEASE; PAGET'S DISEASE; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; VITAMIN D DEFICIENCY;

CALCIUM; MAGNESIUM; OSTEOPOROSIS; PAGET'S DISEASE; PHOSPHORUS; VITAMIN D;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; BONE DISEASES; CALCIUM; HUMANS; MAGNESIUM; OSTEITIS DEFORMANS; OSTEOPOROSIS; PHOSPHORUS; VITAMIN D DEFICIENCY;

EID: 84890808449     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4087-0.00058-9     Document Type: Chapter

References (134)

1. Abad E.P., Perez M., Alarcon T., et al. Epidemiological evidence of multiple sclerosis in Ecuador. Mult Scler 2008, 14(Suppl 1):S55-S56.
2. Agus M.S., Agus Z.S. Cardiovascular actions of magnesium. Crit Care Clin 2001, 17:175-186.
3. Al Zahrani A., Levine M.A. Primary hyperparathyroidism. Lancet 1997, 349:1233-1238.
4. Altunbas H., Balci M.K., Yazicioglu G., et al. Hypocalcemic cardiomyopathy due to untreated hypoparathyroidism. Horm Res 2003, 59:201-204.
5. Al-Tweigeri T., Magliocco A.M., DeCoteau J.F. Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature. Gynecol Oncol 1999, 72:120-122.
6. Ambrogini E., Cetani F., Cianferotti L., et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective randomized clinical trial. J Clin Endocrinol Metab 2007, 92:3114-3121.
7. Andersson P., Rydberg E., Willenheimer R. Primary hyperparathyroidism and heart disease - a review. Eur Heart J 2004, 25:1776-1787.
8. Ankrom M.A., Shapiro J.R. Paget's disease of bone (osteitis deformans). J Am Geriatr Soc 1998, 46:1025-1033.
9. Ariyan C.E., Sosa J.A. Assessment and management of patients with abnormal calcium. Crit Care Med 2004, 32(Suppl):S146-S154.
10. Baas D., Prufer K., Ittel M.E., et al. Rat oligodendrocytes express the vitamin D(3). receptor and respond to 125-dihydroxyvitaminD(3). Glia 2000, 31:59-68.
11. Baimbridge K.G., Celio M.R., Rogers J.H. Calcium-binding proteins in the nervous system. Trends Neurosci 1992, 15:303-308.
12. Baksi S.N., Hughes M.J. Chronic vitamin D deficiency in the weanling rat alters catecholamine metabolism in the cortex. Brain Res 1982, 242:387-390.
13. Beck C., Morbach H., Stenzel M., et al. Hypophosphatasia. Klin Padiatr 2009, 221:219-226.
14. Becker C. Pathophysiology and clinical manifestations of osteoporosis. Clin Cornerstone 2008, 9:42-47.
15. Beer M.H., Porter R.S., Jones T.V. The Merck Manual of Diagnosis and Therapy 2006.
16. Bilezikian J.P. Primary hyperparathyroidism. When to observe and when to operate. Endocrinol Metab Clin North Am 2000, 29:465-478.
17. Bilezikian J.P., Brandi M.L., Rubin M., et al. Primary hyperparathyroidism: new concepts in clinical densitometric and biochemical features. J Intern Med 2005, 257:6-17.
18. Blick S.K., Dhillon S., Keam S.J. Teriparatide: a review of its use in osteoporosis. Drugs 2008, 68:2709-2737.
19. Blondel B., Fuentes S., Metellus P., et al. Severe thoracolumbar osteoporotic burst fractures: treatment combining open kyphoplasty and short-segment fixation. Orthopaedics and Traumatology Surgery and Research 2009, 95:359-364.
20. Bollerslev J., Jansson S., Mollerup C.L., et al. Medical observation compared with parathyroidectomy for asymptomatic primary hyperparathyroidism: a prospective randomized trial. J Clin Endocrinol Metabol 2007, 92:1687-1692.
21. Bone H.G. Nonmalignant complications of Paget's disease. J Bone Miner Res 2006, 21(Suppl 2):P64-P68.
22. Buell J.S., Scott T.M., Dawson-Hughes B., et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009, 64:888-895.
23. Buell J.S., Dawson-Hughes B., Scott T.M., et al. 25-Hydroxyvitamin D dementia and cerebrovascular pathology in elders receiving home services. Neurology 2010, 74:18-26.
24. Burkert R., McGrath J., Eyles D. Vitamin D receptor expression in the embryonic rat brain. Neurosci Res Comm 2003, 33:63-71.
25. Camacho P.M., Painter S., Kadanoff R. Treatment of adult hypophosphatasia with teriparatide. Endocr Pract 2008, 14:204-208.
26. Camadoo L., Tibbott R., Isaza F. Maternal vitamin D deficiency associated with neonatal hypocalcemic convulsions. Nutr J 2007, 6:23.
27. Carvalho A.A., Vieira A., Simplicio H., et al. Primary hyperparathyroidism simulating motor neuron disease: case report. Arq Neuropsiquiatr 2005, 63:160-162.
28. Cass W.A., Smith M.P., Peters L.E. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Ann N Y Acad Sci 2006, 1074:261-271.
29. Chadenat M.L., Dalloz M.A., D'Anglejean J., et al. Primary hyperparathyroidism as a differential diagnosis of Creutzfeldt-Jakob disease. Rev Neurol (Paris) 2009, 165:185-188.
30. Chou Y.Y., Ou H.Y., Wu T.J., et al. Hypophosphatasia in Taiwan: report of two cases. Kaohsiung J Med Sci 2005, 21:134-137.
31. Christophersen N.S., Gronborg M., Petersen T.N., et al. Midbrain expression of delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation. Exp Neurol 2007, 204:791-801.
32. Coker L.H., Rorie K., Cantley L., et al. Primary hyperparathyroidism cognition and health-related quality of life. Ann Surg 2005, 242:642-650.
33. Cooper M.S., Gittoes N.J. Diagnosis and management of hypocalcaemia. BMJ 2008, 336:1298-1302.
34. Dacey M.J. Hypomagnesemic disorders. Crit Care Clin 2001, 17:155-173.
35. Dauphine R.T., Riggs B.L., Scholz D.A. Back pain and vertebral crush fractures: an unemphasized mode of presentation for primary hyperparathyroidism. Ann Intern Med 1975, 83:365-367.
36. Delmas P.D., Meunier P.J. The management of Paget's disease of bone. N Engl J Med 1997, 336:558-566.
37. Delmont E., Roth S., Heudier P., et al. Primary hyperparathyroidism a differential diagnosis of motor neuron diseases. Rev Med Interne 2001, 22:1253-1255.
38. DeViragh P.A., Haglid K.G., Celio M.R. Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci U S A 1989, 86:3887-3890.
39. Eyles D., Brown J., Mackay-Sim A., et al. Vitamin D3 and brain development. Neuroscience 2003, 118:641-653.
40. Eyles D.W., Smith S., Kinobe R., et al. Distribution of the vitamin D receptor and 1alpha-hydroxylase in human brain. J Chem Neuroanat 2005, 29:21-30.
41. Féron F., Burne T.H., Brown J., et al. Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 2005, 65:141-148.
42. Finiels P.J., Finiels H., Strubel D., et al. Spontaneous osteoporotic fractures of the sacrum causing neurological damage. Report of three cases. J Neurosurg 2002, 97(Suppl):380-385.
43. Galland L. Magnesium stress and neuropsychiatric disorders. Magnes Trace Elem 1991, 10:287-301.
44. Garcion E., Wion-Barbot N., Montero-Menei C.N., et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002, 13:100-105.
45. Geelhoed G.W., Kelly T.R. Pseudogout as a clue and complication of in primary hyperparathyroidism. Surgery 1989, 106:1036-1041.
46. Girschick H.J., Schneider P., Haubitz I., et al. Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet J Rare Dis 2006, 1:24.
47. Goswami R., Bhatia M., Goyal R., et al. Reversible peripheral neuropathy in idiopathic hypoparathyroidism. Acta Neurol Scand 2002, 105:128-131.
48. Hadjipavlou A.G., Gaitanis L.N., Katonis P.G., et al. Paget's disease of the spine and its management. Eur Spine J 2001, 10:370-384.
49. Hansen M.F., Seton M., Merchant A. Osteosarcoma in Paget's disease of bone. J Bone Miner Res 2006, 21(Suppl 2):P58-P63.
50. Heaney R. Vitamin D endocrine physiology. J Bone Miner Res 2007, 22(Suppl 2):V25-V27.
51. Hirose M., Kobayashi M., Sudo S. Hemodialysis for toxic hypermagnesemia caused by intravenous magnesium in a woman with eclampsia and renal insufficiency. A case report. J Reprod Med 2002, 47:1050-1052.
52. Holick M.F., Lim R., Dighe A.S. Case records of the Massachusetts General Hospital. Case 3-2009. A 9-month-old boy with seizures. N Engl J Med 2009, 360:398-407.
53. Hoogendijk W.J., Lips P., Dik M.G., et al. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008, 65:508-512.
54. Hullar T.E., Lustig L.R. Paget's disease and fibrous dysplasia. Otolaryngol Clin North Am 2003, 36:707-732.
55. Ito Y., Hasegawa Y., Toda K., et al. Pathogenesis and diagnosis of delayed vertebral collapse resulting from osteoporotic spinal fracture. Spine J 2002, 2:101-106.
56. Jabr F.I., Matari H.M., Prempeh A.L. Extensive intracranial bilateral symmetrical calcification secondary to hypoparathyroidism. Arch Neurol 2004, 61:281.
57. Jorde R., Sneve M., Figenschau Y., et al. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008, 264:599-609.
58. Josse R.G., Hanley D.A., Kendler D., et al. Diagnosis and treatment of Paget's disease of bone. Clin Invest Med 2007, 30:E210-E223.
59. Kang H., Schuman E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 1995, 267:1658-1662.
60. Kazmi A.S., Wall B.M. Reversible congestive heart failure related to profound hypocalcemia secondary to hypoparathyroidism. Am J Med Sci 2007, 333:226-229.
61. Keisala T., Minasyan A., Lou Y.R., et al. Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 2009, 115:91-97.
62. Khan A., Bilezikian J. Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 2000, 163:184-187.
63. Ko P., Burkert R., McGrath J., et al. Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. Dev Brain Res 2004, 153:61-68.
64. Kowdley K.V., Coull B.M., Orwoll E.S. Cognitive impairment and intracranial calcification in chronic hypoparathyroidism. Am J Med Sci 1999, 317:273-277.
65. Kuro-o M. Endocrine FGFs and Klothos: emerging concepts. Trends Endocrinol Metab 2008, 19:239-245.
66. Langub M.C., Herman J.P., Malluche H.H., et al. Evidence of functional vitamin D receptors in rathippocampus. Neuroscience 2001, 104:49-56.
67. Lewiecki E.M. Denosumab update. Curr opin Rheumatol 2009, 21:369-373.
68. Liamis G., Milionis H.J., Elisaf M. A review of drug-induced hypocalcemia. J Bone Miner Metab 2009, 27:635-642.
69. Litmanovitz I., Reish O., Dolfin T., et al. Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions. J Inherit Metab Dis 2002, 25:35-40.
70. Marx S.J. Medical progress: hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000, 343:1863-1875.
71. Meca J.E., Molto-Jorda J.M., Morales-Ortiz A., et al. Neurological manifestations of Paget's disease: presentation of one case and review of the literature. Rev Neurol 1997, 25:1076-1078.
72. Mejdoubi M., Zegermann T. Neurological picture. Extensive brain calcification in idiopathic hypoparathyroidism. J Neurol Neurosurg Psychiatry 2006, 77:1328.
73. Menon B., Harinaryan C.V. The effect of anti epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism - a longitudinal study. Seizure 2010, 19:153-158.
74. Miller W.L., Portale A.A. Vitamin D 1 alphahydroxylase. Trends Endocrinol Metab 2000, 11:315-319.
75. Mintzer S., Boppana P., Toguri J., et al. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006, 47:510-515.
76. Mittendorf E.A., Wefel J.S., Meyers C.A., et al. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract 2007, 13:338-344.
77. Moe S.M. Disorders involving calcium, phosphorus, and magnesium. Prim Care 2008, 35:215-237.
78. Monsell E.M., Cody D.D., Bone H.G., et al. Hearing loss as a complication of Paget's disease of bone. J Bone Miner Res 1999, 14(Suppl 2):92-95.
79. Mornet E. Hypophosphatasia. Orphanet J Rare Dis 2007, 2:40.
80. Morris G.S., Grubbs E.G., Hearon C.M., et al. Parathyroidectomy improves functional capacity in asymptomatic older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg 2010, 251:832-837.
81. Moulin P., Vaysse F., Bieth E., et al. Hypophosphatasia may lead to bone fragility: don't miss it. Eur J Pediatr 2009, 168:783-788.
82. Mouw D.R., Latessa R.A., Hickner J. Clinical inquiries. What are the causes of hypomagnesemia?. J Fam Pract 2005, 54:174-176.
83. Munger K.L., Levin L.I., Hollis B.W., et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832-2838.
84. Musiol I.M., Stumpf W.E., Bidmon H.J., et al. Vitamin D nuclear binding to neurons of the septal substriatal and amygdaloid area in the Siberian hamster (Phodopus sungorus) brain. Neuroscience 1992, 48:841-848.
85. Nguyen H.V., Ludwig S., Gelb D. Osteoporotic vertebral burst fractures with neurologic compromise. J Spinal Disord Tech 2003, 16:10-19.
86. Nunes M.L., Mugnol F., Bica I., et al. Pyridoxine-dependent seizures associated with hypophosphatasia in a newborn. J Child Neurol 2002, 17:222-224.
87. Obradovic D., Gronemeyer H., Lutz B., et al. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 2006, 96:500-509.
88. Palma G. Carpal tunnel syndrome and hyperparathyroidism. Ann Neurol 1983, 14:592.
89. Pan A., Lu L., Franco O.H., et al. Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J Affect Disord 2009, 118:240-243.
90. Perrier N.D., Balachandran D., Wefel J.S., et al. Prospective randomized controlled trial of parathyroidectomy versus observation in patients with asymptomatic primary hyperparathyroidism. Surgery 2009, 146:1116-1122.
91. Pierrot-Deseilligny C. Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 2009, 256:1468-1479.
92. Poncelet A. The neurologic complications of Paget's disease. J Bone Miner Res 1999, 14:88-91.
93. Prufer K., Veenstra T.D., Jirikowski G.F., et al. Distribution of 125-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat 1999, 16:135-145.
94. Ralston S.H. Pathogenesis of Paget's disease of bone. Bone 2008, 43:819-825.
95. Raubenheimer P.J., Taylor A.G., Soule S.G. Paget's disease complicated by hydrocephalus and syringomyelia. Br J Neurosurg 2002, 16:513-516.
96. Reid I.R. Anti-resorptive therapies for osteoporosis. Semin Cell Dev Biol 2008, 19:473-478.
97. Riggs J.E. Neurologic manifestations of electrolyte disturbances. Neurol Clin 2002, 20:227-239.
98. Roman S., Sosa J.A. Psychiatric and cognitive aspects of primary hyperparathyroidism. Curr Opin Oncol 2007, 19:1-5.
99. Roman S.A., Sosa J.A., Mayes L., et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 2005, 138:1121-1128. discussion 1128-1129.
100. Rose C.R., Blum R., Pichler B., et al. Truncated TrkB-T1 mediates neurotrophin- evoked calcium signalling in glia cells. Nature 2003, 426:74-78.
101. Rude R.K., Olerich M. Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporos Int 1996, 6:453-461.
102. Sankaran S., Gamble G., Bolland M., et al. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metabol 2010, 95:1653-1662.
103. Schaller B., Andres R.H., Huber A.W., et al. Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons. Brain Res 2005, 1036:163-172.
104. Schwaller B., Meyer M., Schiffmann S. "New" functions for "old" proteins: the role of the calcium-binding proteins calbindin D-28k calretinin and parvalbumin in cerebellar physiology Studies with knockout mice. Cerebellum 2002, 1:241-258.
105. Shiber J.R., Mattu A. Serum phosphate abnormalities in the emergency department. J Emerg Med 2002, 23:395-400.
106. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med 2008, 359:391-403.
107. Shonka D.C., Kesser B.W. Paget's disease of the temporal bone. Otol Neurotol 2006, 27:1199-1200.
108. Siegel G.J., Agranoff B.W., Albers R.W., et al. Basic Neurochemistry: Molecular Cellular and Medical Aspects 1999, Lippincott Williams and Wilkins, Philadelphia. 6th edn.
109. Silverberg S.J. Non-classical target organs in primary hyperparathyroidism. J Bone Miner Res 2002, 17(Suppl 2):N117-N125.
110. Silverberg S.J., Lewiecki E.M., Mosekilde L., et al. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metabol 2009, 94:351-365.
111. Siris E.S., Lyles K.W., Singer F.R., et al. Medical management of Paget's disease of bone: indications for treatment and review of current therapies. J Bone Miner Res 2006, 21(Suppl 2):P94-P98.
112. Smilari P., Romeo D.M., Palazzo P., et al. Neonatal hypophosphatasia and seizures. A case report. Minerva Pediatr 2005, 57:319-323.
113. Smolders J., Thewissen M., Peelen E., et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009, 4:e6635.
114. Sontia B., Touyz R.M. Role of magnesium in hypertension. Arch Biochem Biophys 2007, 458:33-39.
115. Stio M., Lunghi B., Iantomasi T., et al. Effect of vitamin D deficiency and 125-dihydroxyvitamin D3 on metabolism and D-glucose transport in rat cerebral cortex. J Neurosci Res 1993, 35:559-566.
116. Taniura H., Ito M., Sanada N., et al. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 2006, 83:1179-1189.
117. Taupin P., Gage F.H. Adult neurogenesis and neural stem cells of the central nervous system in mammals. J Neurosci Res 2002, 69:745-749.
118. Tekes K., Gyenge M., Folyovich A., et al. Influence of neonatal vitamin A and vitamin D on the concentration of biogenic amines and their metabolites in the rat brain. Horm Metab Res 2009, 41:277-280.
119. Tessitore E., Luzi M., Lobrinus J.A., et al. Cervical Paget disease of bone with spinal cord compression due to atlanto-axial instability: a case report and review of the literature. Spine 2008, 33:E85-E89.
120. Tezer M., Ozturk C., Erturer E., et al. Bilateral L5 radiculopathy due to osteoporotic L1 vertebral fracture: a case report. J Spinal Cord Med 2006, 29:430-435.
121. Topf J.M., Murray P.T. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord 2003, 4:195-206.
122. Verulashvili I.V., Glonti L.S., Miminoshvili D.K., et al. Basal ganglia calcification: clinical manifestations and diagnostic evaluation. Georgian Med News 2006, 140:39-43.
123. Volpe S.L. Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit Rev Food Sci Nutr 2008, 48:293-300.
124. Walbert T., Jirikowski G.F., Prufer K. Distribution of 125-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat. Horm Metab Res 2001, 33:525-531.
125. Walker M.D., Silverberg S.J. Parathyroidectomy in asymptomatic primary hyperparathyroidism: improves bones but not psychic moans. J Clin Endocrinol Metabol 2007, 92:1613-1615.
126. Walker M.D., McMahon D.J., Inabnet W.B., et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metabol 2009, 94:1951-1958.
127. Watts C., McConkey H., Anderson L., et al. Anatomical perspectives on adult neural stem cells. J Anat 2005, 207:197-208.
128. Weber T., Keller M., Hense I., et al. Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg 2007, 31:1202-1209.
129. Weisinger J.R., Bellorin-Font E. Magnesium and phosphorus. Lancet 1998, 352:391-396.
130. Whyte M.P., Mumm S., Deal C. Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metabol 2007, 92:1203-1208.
131. Whyte M.P., Wenkert D., McAlister W.H., et al. Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia. J Bone Miner Res 2009, 24:1493-1505.
132. Woo N.H., Lu B. Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 2006, 12:43-56.
133. Yamamoto H., Sasamoto Y., Miyamoto Y., et al. A successful treatment with pyridoxal phosphate for West syndrome in hypophosphatasia. Pediatr Neurol 2004, 30:216-218.
134. Zou J., Minasyan A., Keisala T., et al. Progressive hearing loss in mice with a mutated vitamin D receptor gene. Audiol Neurootol 2008, 13:219-230.